BGC vs CME
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 14, 2026
BGC
54.9
AI Score
VS
BGC Wins
CME
34.6
AI Score
Investment Advisor Scores
CME
35score
Recommendation
SELL
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | BGC | CME | Winner |
|---|---|---|---|
| Revenue | 1.80B | 3.59B | CME |
| Net Income | 156.63M | 2.20B | CME |
| Net Margin | 8.7% | 61.2% | CME |
| ROE | 14.2% | 8.3% | BGC |
| ROA | 2.7% | 1.1% | BGC |
| Total Assets | 5.75B | 194.68B | CME |
| Cash | 766.85M | 2.14B | CME |
| Free Cash Flow | 172.09M | 2.16B | CME |
Relative Price Performance (Last 90 Days)
BGC 1M: -1.8%
· 3M: -1.9%
CME 1M: +9.6%
· 3M: -9.4%
Current Technical Phase
BGC
NeutralHold
Mixed signals - no dominant trend phase, RSI 52
CME
NeutralHold
Mixed signals - no dominant trend phase, RSI 64
Fundamentals Snapshot
| Metric | BGC | CME |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.1 | 20.9 |
| Trailing P/E | 26.7 | 22.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.9% | 1.0% |
| Operating Margin | 0.1% | 0.7% |
| EPS | 0.41 | 12.02 |
| Dividend Yield | 0.01% | 0.02% |
Frequently Asked Questions
Based on our detailed analysis, BGC is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.